Form D · Other

Apex Neuro Holdings, Inc.

Brooklyn, NY · CIK 0001783115

Offering snapshot reported Mar 23, 2022 · SEC filing

Reported sold
$4M
Offering amount: $10M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 8, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 23, 2022Initial$4,000,000No comparison1SEC filing
Nov 26, 2019Amendment$20,000,004$1,999,999vs Nov 8, 20195SEC filing
Nov 8, 2019Initial$18,000,005No comparison4SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-438604

Source: Form D, filed Mar 23, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Hunter Bergschneider Executive
Zen Chu Director
Adam D'augelli Director
Adam D?Augelli Director
Francois Kress Director, Executive
Robert Nelsen Director
Latif Peracha Director
Lis Rhodes Executive

Issuer details

Industry: Other (See others in industry)

Address:
370 Jay St., 7 Th Fl.
Brooklyn, NY, 11201